NHP Covid Patient Info on vaccination

CSL Behring‘s HEMOPEXIN FIRST IN HUMAN STUDY IN STABLE SICKLE DISEASE Study Title: A Phase 1, Multi-Center, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics

Thalassaemia Questionnaire

If your a patient that suffers from Sickle Cell or Thalassaemia or even knows somebody that does, then we would love to hear from you. STSTN are looking for articles